These results, along with reports that autophagy induction reduces mutant ataxin-3 levels and toxicity in a SCA3 mouse model [36], suggest that targeting cytoplasmic HMGB1 to increase the clearance of mutant polyQ proteins may provide a potential therapeutic approach for SCA17. Here, HMGB1 is linked to spinocerebellar ataxia type 17.